LEIDEN, Netherlands (AP) — LEIDEN, Netherlands (AP) — ProQR Therapeutics NV (PRQR) on Tuesday reported a loss of $9.6 million in its first quarter.
On a per-share basis, the Leiden, Netherlands-based company said it had a loss of 12 cents.
The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 12 cents per share.
The Dutch drugmaker posted revenue of $702,700 in the period. Its adjusted revenue was $703,000.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRQR at https://www.zacks.com/ap/PRQR
/Computer%20board%20micro%20chip%20green%20by%20blickpixel%20via%20Pixabay.jpg){kind=tracking}
